When did Hemab Therapeutics Holdings Inc go public?

Hemab Therapeutics Holdings Inc completed its IPO on May 1, 2026 on NASDAQ Global Select under the ticker COAG and now trades publicly.

What was Hemab Therapeutics Holdings Inc's IPO price?

Hemab Therapeutics Holdings Inc priced its IPO at $18.00 per share.

Can I buy Hemab Therapeutics Holdings Inc stock?

Yes — Hemab Therapeutics Holdings Inc is publicly traded on NASDAQ Global Select as COAG. You can follow its live price, valuation and post-IPO performance above.

What is Hemab Therapeutics Holdings Inc's valuation?

Hemab Therapeutics Holdings Inc's most recent valuation tracked here is $2.13B, derived from live market prices.

All companies

Hemab Therapeutics Holdings Inc

COAG

PublicArchived

Public / ArchivedUnited States(NASDAQ Global Select)Best valuation $2.13BSince IPO +153.39%1 market

Public listing

Listed· NASDAQ Global Select· Listing market: United States

Listing date

May 1, 2026

Final IPO price

$18.00

Shares offered

16,750,000

Offering proceeds

$301.5M

Sources: SEC EDGAR, Nasdaq

IPO Calendar · NASDAQIPO

COAG

Price

$45.61

24h

+1.15%

Valuation

$2.13B

24h volume

$20.81M

Type

IPO

Market source

Hemab Therapeutics Holdings Inc trades publicly. Prices are daily closing quotes.

View on Nasdaq

IPO Calendar · updated 18m ago

About Hemab Therapeutics Holdings Inc

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies aimed at reimagining the treatment of blood coagulation disorders. The business is focused on translating drug-development programs through clinical research rather than generating near-term operating revenue from product sales, with progress reflected in study milestones and regulatory/clinical updates.

SEC IPO filings

Final prospectus

EDGAR filings resolved from COAG / CIK 0002114044.

424B4424B4

May 1, 2026Final prospectus0001193125-26-201458

EFFECTxslEFFECTX01/primary_doc.xml

Apr 30, 2026Effective9999999995-26-001409

CERTCOAG_8A_Cert_2114044.pdf

Apr 30, 2026Exchange registration0001354457-26-000393

S-1/AS-1/A

Apr 30, 2026Amended0001193125-26-193885

S-1/AS-1/A

Apr 28, 2026Amended0001193125-26-186964

8-A12B8-A12B

Apr 27, 2026Exchange registration0001193125-26-181893

S-1/AS-1/A

Apr 27, 2026Amended0001193125-26-178809

S-1S-1

Apr 10, 2026Filed0001193125-26-151378

DRS/Afilename1.htm

Apr 2, 2026Confidential draft0001193125-26-140464

DRSfilename1.htm

Feb 27, 2026Confidential draft0001193125-26-081986

Hemab Therapeutics Holdings Inc IPO — frequently asked questions

When did Hemab Therapeutics Holdings Inc go public?: Hemab Therapeutics Holdings Inc completed its IPO on May 1, 2026 on NASDAQ Global Select under the ticker COAG and now trades publicly.
What was Hemab Therapeutics Holdings Inc's IPO price?: Hemab Therapeutics Holdings Inc priced its IPO at $18.00 per share.
Can I buy Hemab Therapeutics Holdings Inc stock?: Yes — Hemab Therapeutics Holdings Inc is publicly traded on NASDAQ Global Select as COAG. You can follow its live price, valuation and post-IPO performance above.
What is Hemab Therapeutics Holdings Inc's valuation?: Hemab Therapeutics Holdings Inc's most recent valuation tracked here is $2.13B, derived from live market prices.